Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Modular Medical, Inc.
Report date April 26, 2017 · Filed April 27, 2017
Section 16 reporting ended · disclosed 2017-04-27. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 104,083 |
Reported balance
After 2017-04-26 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-04-26 · Sale · Disposed 181,633 · Balance 104,083 F2: 181,633 shares were cancelled to the Company for an aggregate price of $4,000 pursuant to a Common Stock Purchase Agreement dated April 5, 2017 (the "Agreement"), and filed with the Securities and Exchange Commission on that date; the Agreement was closed and completed on April 26, 2017, at which time Mr. Albiston's resignation as an officer and director became effective. F1: These shares reflect a 3.5 for 1 reverse stock split effective October 23, 2006. The previous ownership reported was 1,000,000 shares beneficially owned, which after the reverse and rounding equals 285,716 shares beneficially owned. |
| Common StockSEC Table I · non-derivative | Direct | 21,667 |
Reported balance
After 2017-04-26 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2017-04-26 · Sale · Disposed 82,416 · Balance 21,667 F3: Mr. Albiston sold 82,416 shares to a person who may be deemed to have been a related party of the Company at $0.02 per share for an aggregate purchase price of $1,648.32. |
| Common StockSEC Table I · non-derivative | Direct | 15,000 |
Reported balance
After 2017-04-26 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2017-04-26 · Sale · Disposed 6,667 · Balance 15,000 F4: Mr. Albiston sold 6,667 shares to a former legal counsel of the Company at $0.02 per share for an aggregate purchase price of $133.34. F5: The Agreement required that the remaining 15,000 shares owned by Mr. Albiston be pledged to the Company for a period of 12 months under an Indemnification Escrow Agreement and an Indemnification Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares reflect a 3.5 for 1 reverse stock split effective October 23, 2006. The previous ownership reported was 1,000,000 shares beneficially owned, which after the reverse and rounding equals 285,716 shares beneficially owned.
F2: 181,633 shares were cancelled to the Company for an aggregate price of $4,000 pursuant to a Common Stock Purchase Agreement dated April 5, 2017 (the "Agreement"), and filed with the Securities and Exchange Commission on that date; the Agreement was closed and completed on April 26, 2017, at which time Mr. Albiston's resignation as an officer and director became effective.
F3: Mr. Albiston sold 82,416 shares to a person who may be deemed to have been a related party of the Company at $0.02 per share for an aggregate purchase price of $1,648.32.
F4: Mr. Albiston sold 6,667 shares to a former legal counsel of the Company at $0.02 per share for an aggregate purchase price of $133.34.
F5: The Agreement required that the remaining 15,000 shares owned by Mr. Albiston be pledged to the Company for a period of 12 months under an Indemnification Escrow Agreement and an Indemnification Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 26, 2017 Filed Apr 27, 2017 17:57 UTC | Modular Medical, Inc. BLKE · Entity 7488 | SaleCommon Stock | 6,667 | $0.02 | $133.34 |
DisclosureSEC source: 0001010412-17-000019 · primary_doc.xml · nonDerivative · entry 3 ALBISTON TODD L · CIK 0001304681 · Former Sec., Trea and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F4 · shares: Mr. Albiston sold 6,667 shares to a former legal counsel of the Company at $0.02 per share for an aggregate purchase price of $133.34. F5 · balance_after: The Agreement required that the remaining 15,000 shares owned by Mr. Albiston be pledged to the Company for a period of 12 months under an Indemnification Escrow Agreement and an Indemnification Agreement. Read SEC document |
| April 26, 2017 Filed Apr 27, 2017 17:57 UTC | Modular Medical, Inc. BLKE · Entity 7488 | SaleCommon Stock | 82,416 | $0.02 | $1,648.32 |
DisclosureSEC source: 0001010412-17-000019 · primary_doc.xml · nonDerivative · entry 2 ALBISTON TODD L · CIK 0001304681 · Former Sec., Trea and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,667 F3 · shares: Mr. Albiston sold 82,416 shares to a person who may be deemed to have been a related party of the Company at $0.02 per share for an aggregate purchase price of $1,648.32. Read SEC document |
| April 26, 2017 Filed Apr 27, 2017 17:57 UTC | Modular Medical, Inc. BLKE · Entity 7488 | SaleCommon Stock | 181,633 | $0.02 | $3,995.93 |
DisclosureSEC source: 0001010412-17-000019 · primary_doc.xml · nonDerivative · entry 1 ALBISTON TODD L · CIK 0001304681 · Former Sec., Trea and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,083 F2 · shares: 181,633 shares were cancelled to the Company for an aggregate price of $4,000 pursuant to a Common Stock Purchase Agreement dated April 5, 2017 (the "Agreement"), and filed with the Securities and Exchange Commission on that date; the Agreement was closed and completed on April 26, 2017, at which time Mr. Albiston's resignation as an officer and director became effective. F1 · balance_after: These shares reflect a 3.5 for 1 reverse stock split effective October 23, 2006. The previous ownership reported was 1,000,000 shares beneficially owned, which after the reverse and rounding equals 285,716 shares beneficially owned. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.